Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 8/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22030391 | 0.92 | ALDH1A1 (0.41) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL471729 | 0.91 | ALDH1A1 (0.50) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL22030393 | 0.90 | ALDH1A1 (0.42) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL22030392 | 0.89 | ALDH1A1 (0.49) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL24530434 | 0.88 | KMT2A (0.42) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL18711241 | 0.82 | KMT2A (0.48) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL259671 | 0.82 | ACE2 (0.47) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL20734660 | 0.82 | KMT2A (0.48) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL22341390 | 0.81 | KMT2A (0.54) | ALDH1A1KMT2ARAB9AKDM4ELMNA | |
| SCHEMBL14426096 | 0.81 | ALDH1A1 (0.42) | ALDH1A1KMT2ARAB9AKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3596039-B1 | PROCESS FOR MANUFACTURING CHAIN-EXTENDED HYDROXYETHYLETHYLENEAMINES, ETHYLENEAMINES, OR MIXTURES THEREOF | NOURYON CHEMICALS INT BV (NL) | 2021-05-05 | — | — | EP | disclosed |
| US-20200131136-A1 | PROCESS FOR MANUFACTURING CHAIN-EXTENDED HYDROXYETHYLETHYLENEAMINES, ETHYLENEAMINES, OR MIXTURES THEREOF | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200131136-A1 | PROCESS FOR MANUFACTURING CHAIN-EXTENDED HYDROXYETHYLETHYLENEAMINES, ETHYLENEAMINES, OR MIXTURES THEREOF | HNMT, PNMT, HRH2 | ALDH1A1 1004/4885KMT2A 446/4885RAB9A 1631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.